Accessibility Menu
Utah Medical Products Stock Quote

Utah Medical Products (NASDAQ: UTMD)

$61.20
(1.2%)
+0.75
Price as of October 22, 2025, 1:09 p.m. ET

KEY DATA POINTS

Current Price
$61.2
Daily Change
(1.2%) +$0.75
Day's Range
$60.91 - $61.2
Previous Close
$60.45
Open
$60.92
Beta
0.56
Volume
6
Average Volume
10,188
Market Cap
193.8M
Market Cap / Employee
$60.45M
52wk Range
$51.26 - $68.99
Revenue
-
Gross Margin
0.52%
Dividend Yield
2.02%
EPS
$3.74
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Utah Medical Products Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
UTMD-6.17%-21.16%-4.64%+4,946%
S&P+15.06%+95.03%+14.29%+2,212%

Utah Medical Products Company Info

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$9.95M-4.3%
Gross Profit$5.06M-12.0%
Gross Margin50.80%-4.4%
Market Cap$184.89M-21.6%
Market Cap / Employee$1.07M0.0%
Employees173-12.2%
Net Income$3.05M-11.7%
EBITDA$3.95M-4.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$82.18M-7.9%
Accounts Receivable$3.63M-1.0%
Inventory8.2-9.1%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.26M-6.9%
Short Term Debt$0.00M0.0%

Ratios

Q2 2025YOY Change
Return On Assets10.01%-2.0%
Return On Invested Capital12.66%-0.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$2.82M6.4%
Operating Free Cash Flow$2.87M4.0%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings15.6515.5514.8415.22-1.25%
Price to Book1.851.701.591.60-14.97%
Price to Sales5.285.094.724.76-6.07%
Price to Tangible Book Value2.161.981.851.85-15.26%
Price to Free Cash Flow TTM18.4420.1419.6519.0711.29%
Enterprise Value to EBITDA35.4134.3226.4426.01-26.92%
Free Cash Flow Yield5.4%5.0%5.1%5.2%-10.14%
Return on Equity12.3%11.3%10.6%10.4%-18.27%
Total Debt$0.30M$0.34M$0.27M$0.26M-6.91%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.